Product Description
The global gastric device market was valued at over $124 million in 2025. The market is expected to grow modestly over the forecast period at a CAGR of approximately 1.1%, reaching approximately $134 million by 2032.
The full report suite on the global market for gastric devices includes gastric balloons and gastric bands; however, gastric bands now represent a very small and declining portion of the market. Even adjustable band systems, such as legacy LAP-BAND® platforms, have experienced sustained contraction due to long-term complication rates, revision procedures, and shifting surgeon preference toward other bariatric techniques.
The report includes data for 65+ countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Gastric Device Market Trends
Patients who choose gastric devices often do so because they prefer reversible intervention and wish to avoid permanent anatomical modification, such as that involved in sleeve gastrectomy. This psychological and procedural reversibility continues to differentiate balloons from surgical alternatives.
Global Gastric Device Market Share Insights
- Allurion Technologies is a key competitor in the global gastric balloon market, offering the Allurion® Balloon system, a swallowable, procedure-light weight loss solution designed to avoid endoscopy for placement and removal. The platform is positioned as a minimally invasive and reversible alternative to both surgical bariatric procedures and traditional endoscopic balloons. In February 2026, Allurion received U.S. FDA premarket approval for its gastric balloon system for short-term weight loss in combination with lifestyle intervention, marking its formal entry into the U.S. market. This regulatory milestone significantly expands the company’s commercial footprint and strengthens its competitive positioning within the North American gastric device segment.
- Boston Scientific maintained a notable presence in the gastric device segment following the integration of Apollo Endosurgery into its portfolio. The company’s position in this space is supported by endoluminal and bariatric-adjacent technologies, including the OverStitch™ endoscopic suturing system, which complements Boston Scientific’s broader minimally invasive and gastrointestinal surgery franchise.
- Medtimo (formerly ReShape Lifesciences) remained a niche competitor in the gastric device market in 2025, primarily associated with the legacy LAP-BAND® adjustable gastric banding system. While Medtimo continues to pursue development of additional obesity treatment technologies, including balloon-based solutions, these products have not yet been commercially launched and therefore do not materially contribute to market revenue as of 2025.
Global Gastric Device Market Segmentation Summary
- Gastric Band Market
- Gastric Balloon Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis for Top Competitors, Mergers & Acquisitions, Emerging Markets & Technologies, Key Analysis Updates. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
